Study of Nivolumab Given Sequentially With Ipilimumab in Subjects With Advanced or Metastatic Melanoma (CheckMate 064)
Clinical trial NCT01783938 · COMPLETED
Trial details
- NCT number
- NCT01783938
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-30
- Primary completion
- 2015-04-03
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.